Cell Therapy, cGMP Manufacturing March 29, 2023 RoslinCT and Lykan Bioscience announce that the MHRA has granted an MIA License for their cGMP Manufacturing facilities in Edinburgh, UK
Cell Therapy Manufacturing, eBook, Variability March 06, 2023 Four Keys to Reducing Variability in the Cell Therapy Process
Leadership, New cGMP suites, Partnerships, Site Expansion February 23, 2023 RoslinCT and Lykan Bioscience Announce the Addition of Six cGMP Suites to Meet Growing Demand
Leadership, Partnerships, Scientific Advisor January 10, 2023 RoslinCT and Lykan Bioscience Announce the Appointment of Dr. Michael Mendicino to its Scientific Advisory Board
Cell Therapy, eBook, Tech Transfer November 01, 2022 [EBOOK] Key Considerations for a Successful Cell Therapy Tech Transfer
Leadership September 19, 2022 Lykan Bioscience Appoints Barbara Ressler, Ph.D. as Vice President, Manufacturing Process Sciences
Leadership, Partnerships September 12, 2022 Lykan Bioscience and RoslinCT Announce the Establishment of a Scientific Advisory Board